Useful Resources for Ankylosing Spondylitis

These resources offer more information about Ankylosing Spondylitis

New Zealand Resources

The following resources have been compiled to help you get support outside the HUMIRA AbbVie Care programme. We hope you find them useful.

Medsafe Consumer Information

Download Consumer Medicine Information (PDF)

Arthritis New Zealand

A national voluntary organisation which represents the interests of those with arthritis. It contains information on the condition and its treatment.

www.arthritis.org.nz

New Zealand Rheumatology Association

The New Zealand Rheumatology Association (NZRA) is the organisation that represents the rheumatologists of New Zealand.

You can use this resource to find a rheumatologist near you

www.rheumatology.org.nz

Overseas Resources

Please note that treatment available in other countries may not be available in New Zealand.

Arthritis Australia

An Australian national organisation which represents the interests of those with arthritis. You’ll find information on the condition and its treatment.

www.arthritisaustralia.com.au

Spondylitis Association of America

The Spondylitis Association of America (SAA) is a nonprofit organisation founded in 1983 to address the needs of people living with spondylitis.

www.spondylitis.org

Arthritis Foundation USA

An American national organisation which represents the interests of those with arthritis. Find information on the condition and its treatment.

www.arthritis.org

American College of Rheumatology

The American College of Rheumatology (ACR) is an ethically-driven, professional membership organization committed to improving the care of patients with rheumatic disease and advancing the rheumatology subspecialty. This site contains information for patients and caregivers.

www.rheumatology.org

Australian Rheumatology Association

The ARA is an association of rheumatologists in Australia that is a specialty society of the Royal Australasian College of Physicians (RACP). This website contains links to condition-specific information sheets from Arthritis Australia.

www.rheumatology.org.au

This site is intended for a New Zealand audience.

Important information about HUMIRA. HUMIRA is a prescription medicine containing adalimumab. HUMIRA is available as a single use pre-filled syringe or single-use pre-filled pen and may contain 20mg, 40mg or 80mg adalimumab. It is used in the treatment of patients with rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, enthesitis-related arthritis, psoriatic arthritis, ankylosing spondylitis, non-radiographic axial spondyloarthritis, psoriasis, ulcerative colitis, Crohn’s disease, non-infectious uveitis, and hidradenitis suppurativa. HUMIRA is only used in patients of a specific age group, in diseases of certain severity (e.g. moderate to severe), and/or after some other treatments have been tried (e.g. conventional therapy).

HUMIRA has risks and benefits. Refer to the Safety Information contained on this website for further details. If you have any questions about using HUMIRA, ask your healthcare professional and refer to the Consumer Medicine Information (CMI) available here: HUMIRA PEN CMI or HUMIRA Pre-filled Syringe CMI or by calling freephone 0800 900 030. Ask your doctor if HUMIRA is right for you. Use strictly as directed. If symptoms continue, or you have side effects, see your doctor, pharmacist or healthcare professional.

HUMIRA is a funded prescription medicine under special authorial criteria – for certain indications and patients only. Your doctor can inform you if you are eligible to receive funding. Normal pharmacy and doctor's charge will apply.

AbbVie is the company that brings you HUMIRA (adalimumab). For more information about AbbVie, visit www.AbbVie.co.nz | HUMIRA Data Sheet

AbbVie Limited, 6th floor, 156-158 Victoria street, Wellington, 6011, New Zealand 0800 900 030. HUMIRA and Destination You are registered trademarks of AbbVie Biotechnology Ltd.